Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny
Abstract The Swedish Medical Products Agency (MPA) objects to the fact that we occasionally refer to one of its senior ex-employees by name. However, names of individual MPA assessors, Food and Drug Administration (FDA) reviewers, and European Medicines Agency rapporteurs and co-rapporteurs are cite...
Saved in:
Main Authors: | Shai Mulinari (Author), Courtney Davis (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews
by: Shai Mulinari, et al.
Published: (2017) -
Study and Scrutiny: Research on Young Adult Literature
by: Crag Hill, et al.
Published: (2020) -
A Scrutiny on the Burnout Levels of Fencing Referees
by: Yusuf Barsbuğa, et al.
Published: (2020) -
Lessons learned about publication of results of community surveys when regulatory oversight has not occurred
by: Christina Roman, et al.
Published: (2022) -
Social and Psychological Aspects of HIV/AIDS and their Ramifications
Published: (2011)